Loading...
Suraksha Diagnostic Limited
SURAKSHA.NS•NSE
Healthcare
Medical - Diagnostics & Research
₹285.66
₹3.18(1.13%)
Indian Market opens in 7h 11mSuraksha Diagnostic Limited (SURAKSHA.NS) AI-Powered Stock Analysis
See how Suraksha Diagnostic Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerSuraksha Diagnostic Limited (SURAKSHA.NS) Stock Overall Grade
Suraksha Diagnostic Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Suraksha Diagnostic Limited's overall stock rating.
Forecast
A+Score
91/100Financial Growth
A+Score
90/100Fundamental Growth
C+Score
56/100Key Ratios
BScore
68/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Suraksha Diagnostic Limited (SURAKSHA.NS) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 91/100 (A+), reflecting high confidence in its potential. Financial Growth (90/100, A+) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (68/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Suraksha Diagnostic Limited stock grade, including financials, comparisons, and forecasts.